Revascularization Effect on CSVD Burden in Carotid Artery Stenosis

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

June 10, 2023

Primary Completion Date

December 31, 2033

Study Completion Date

May 31, 2034

Conditions
Carotid Artery StenosisCerebral Small Vessel Diseases
Interventions
PROCEDURE

carotid artery stenting

Patients were monitored for at least 24 h after surgery, with control for hyperperfusion syndrome, dual antiplatelet therapy was continued for 4-6 weeks, and the postoperative patients have the final residual stenosis of less than 30%, thrombolysis in Myocardial Infarction (TIMI) grade 3, and no dissection or thrombosis. Any surgery-related complications were recorded.

DRUG

drug therapy

Carotid artery stenosis requires taking antiplatelet aggregation drugs and statin lipid-lowering drugs. It can inhibit platelet aggregation, stabilize plaque, reduce vascular inflammatory factors, and prevent further development of atherosclerosis.

Trial Locations (1)

310000

RECRUITING

Zhejiang Provincial People's Hospital, Hangzhou

All Listed Sponsors
lead

Zhejiang Provincial People's Hospital

OTHER